Sunesis Pharma (SNSS) Tops Q3 EPS by 9c

November 3, 2016 9:14 AM EDT

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Sunesis Pharma (NASDAQ: SNSS) reported Q3 EPS of ($0.62), $0.09 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $600 thousand versus the consensus estimate of $600 thousand.

For earnings history and earnings-related data on Sunesis Pharma (SNSS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment